| Morphological identification of neuron types in the rat hippocampus T Szilagyi, K Orban-Kis, E Horváth, J Metz, Z Pap, Z Pavai Rom J Morphol Embryol 52 (1), 15-20, 2011 | 46 | 2011 |
| Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients JA Szász, VA Constantin, K Orbán-Kis, A Rácz, LA Bancu, D Georgescu, ... Neuropsychiatric Disease and Treatment 15, 3187-3195, 2019 | 26 | 2019 |
| Health related quality of life and satisfaction with care of stroke patients in Budapest: A substudy of the EuroHOPE project I Szőcs, B Dobi, J Lám, K Orbán-Kis, U Häkkinen, É Belicza, D Bereczki, ... PloS one 15 (10), e0241059, 2020 | 25 | 2020 |
| Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients VA Constantin, JA Szász, K Orbán-Kis, EC Rosca, M Popovici, A Cornea, ... Neuropsychiatric Disease and Treatment 16, 1835-1844, 2020 | 22 | 2020 |
| Therapeutic strategies in the early stages of Parkinson's disease: a cross-sectional evaluation of 15 years' experience with a large cohort of Romanian patients JA Szasz, K Orban-Kis, VA Constantin, C Peter, I Biro, I Mihaly, K Szegedi, ... NEUROPSYCHIATRIC DISEASE AND TREATMENT 15, 831-838, 2019 | 21 | 2019 |
| Differential effects of sodium channel blockers on in vitro induced epileptiform activities Z Gáll, K Orbán-Kis, T Szilágyi Archives of pharmacal research 40 (1), 112-121, 2017 | 17 | 2017 |
| Dopamine agonists in Parkinson's disease therapy-15 years of experience of the Neurological Clinics from Tîrgu Mureș. A cross-sectional study JA Szasz, C Viorelia, I Mihály, I Biro, C Péter, K Orban-Kis, S Szatmári Ideggyogyaszati szemle 72 (5-6), 187-193, 2019 | 16 | 2019 |
| Amygdala Low-Frequency Stimulation Reduces Pathological Phase-Amplitude Coupling in the Pilocarpine Model of Epilepsy I Mihály, K Orbán-Kis, Z Gáll, ÁJ Berki, RB Bod, T Szilágyi Brain Sciences 10 (11), 856, 2020 | 15 | 2020 |
| Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania JA Szász, S Szatmári, V Constantin, I Mihály, A Rácz, LC Domokos, ... Orvosi hetilap 160 (17), 662-669, 2019 | 15 | 2019 |
| Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease JA Szász, VA Constantin, K Orbán-Kis, LA Bancu, M Ciorba, I Mihály, ... Brain Sciences 11 (7), 826, 2021 | 12 | 2021 |
| The loss of Ivy cells and the hippocampal input modulatory O-LM cells contribute to the emergence of hyperexcitability in the hippocampus. K ORBÁN-KIS, T SZABADI, T SZILÁGYI Romanian journal of morphology and embryology= Revue roumaine de morphologie …, 2015 | 12 | 2015 |
| Untangling the pathomechanisms of temporal lobe epilepsy—The promise of epileptic biomarkers and novel therapeutic approaches T Szilágyi, I Száva, EJ Metz, I Mihály, K Orbán-Kis Brain research bulletin 109, 1-12, 2014 | 12 | 2014 |
| The importance of evaluation of gastrointestinal symptoms in advanced Parkinson’s disease J Szász, S Szatmári, V Constantin, I Mihály, A Rácz, I Török, E Nagy, ... Orvosi hetilap 161 (39), 1681-1687, 2020 | 9 | 2020 |
| Characteristics of dopaminergic treatments in advanced Parkinson's before levodopa-carbidopa intestinal gel infusion: Data from 107 tested patients J Szász, V Constantin, K Orbán-Kis, L Bancu, D Georgescu, J Szederjesi, ... MOVEMENT DISORDERS 33, S171-S171, 2018 | 7 | 2018 |
| One year follow-up after stroke. A preliminary feasibility study in the Józsefváros district of Budapest I Szocs, S Szatmári, K Fekete, K Orbán-Kis, I Vastagh, A Folyovich, A Ajtay, ... Ideggyogyaszati Szemle 65 (3-4), 107-112, 2012 | 7 | 2012 |
| Quantitative characterization of regional differences in the GABAA-receptor α 1-subunit mRNA expression in the rat brain Z Pávai, Z Pap, K Orban-Kis, T Szilagyi Rom. J. Morphol. Embryol 51, 43-47, 2010 | 7 | 2010 |
| Decision-making and duration to accept device-aided therapy in advanced Parkinson’s disease JA Szász, S Szatmári, V Constantin, I Mihály, A Rácz, A Frigy, E Nagy, ... Orvosi Hetilap 162 (21), 839-847, 2021 | 5 | 2021 |
| Spatial memory deficits in juvenile rats with pilocarpine induced temporal lobe epilepsy K Orbán-Kis, I Mihály, I Lukács, RJ Kiss, J Izsák, I Száva, J Metz, ... Acta Medica Marisiensis 60 (5), 191-195, 2014 | 5 | 2014 |
| Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction JA Szász, S Szatmári, V Constantin, I Mihály, Á Török, A Frigy, J Metz, ... Orvosi hetilap 163 (30), 1189-1195, 2022 | 4 | 2022 |
| Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience JA Szász, VA Constantin, K Orbán-Kis, LA Bancu, SM Bataga, M Ciorba, ... Pharmaceutics 14 (6), 1115, 2022 | 4 | 2022 |
